Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia
- PMID: 11408792
- DOI: 10.1159/000054913
Consensus on the Practical Use of Amisulpride, an Atypical Antipsychotic, in the Treatment of Schizophrenia
Abstract
Clinical expectations in schizophrenia treatment have greatly increased since the introduction of new atypical antipsychotics, but the choice of therapeutic strategy has become more complex and reference guidelines are scarce. This paper summarizes the consensus of a broad range of professionals after long-term commercialization in France of an atypical antipsychotic, amisulpride. Participants were from psychiatric hospitals, private clinics, out-patients settings and research; all were experienced with the drug. Discussions focused on the practical use of amisulpride, as, in addition to the double-blind trials information, it may be useful for psychiatrists of other countries to intuitively understand the therapeutic properties of amisulpride. The topics selected include acute psychotic episodes, short- and long-term follow-up, feasibility of treating the initial phase, the elderly and switching treatments. The French experience emphasizes the central role of amisulpride as a first-line treatment of schizophrenia.
Copyright 2001 S. Karger AG, Basel.
Similar articles
-
Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.Am J Psychiatry. 2002 Feb;159(2):180-90. doi: 10.1176/appi.ajp.159.2.180. Am J Psychiatry. 2002. PMID: 11823257
-
Clinical advantages of amisulpride in the treatment of acute schizophrenia.J Int Med Res. 2001 Nov-Dec;29(6):451-66. doi: 10.1177/147323000102900601. J Int Med Res. 2001. PMID: 11803729 Clinical Trial.
-
Focus on amisulpride.Curr Med Res Opin. 2002;18(3):113-7. doi: 10.1185/030079902125000363. Curr Med Res Opin. 2002. PMID: 12094819 Review.
-
Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.Int J Neuropsychopharmacol. 2004 Mar;7 Suppl 1:S15-20. doi: 10.1017/S1461145704004109. Int J Neuropsychopharmacol. 2004. PMID: 14972080
-
Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?Encephale. 2000 Oct;26 Spec No 1:7-11. Encephale. 2000. PMID: 11294060 Review. English, French.
Cited by
-
The use of atypical antipsychotics in French psychiatric hospitals.Pharm World Sci. 2007 Oct;29(5):551-6. doi: 10.1007/s11096-007-9107-1. Epub 2007 Jul 19. Pharm World Sci. 2007. PMID: 17638111
-
The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.BMC Psychiatry. 2005 May 3;5:22. doi: 10.1186/1471-244X-5-22. BMC Psychiatry. 2005. PMID: 15869707 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical